The CCK 2 receptor antagonist, YF476, inhibits Mastomys ECL cell hyperplasia and gastric carcinoid tumor development

Autor: Kidd, M, Siddique, Z-L, Drozdov, I., Gustafsson, B.I., Camp, R.L., Black, J.W., Boyce, M., Modlin, I.M.
Zdroj: In Regulatory Peptides 2010 162(1):52-60
Databáze: ScienceDirect